Archives
Press Releases
advertisement
December 13, 2017
- FDA Approves Sanofi’s Admelog® (insulin lispro injection).
- Adocia announces positive topline study results comparing ultra-rapid insulin BioChaperone® Lispro with Novolog® and Fiasp® in people with type 1 diabetes. See also French Biotech’s Type 1 Diabetes Candidate Ready to Battle it Out with Big Pharma.
December 6, 2017
- JDRF Launches Health Insurance Guide to Help People with Type 1 Diabetes Navigate Common Insurance Challenges.
- Over 122,000 Call on JDRF, ADA to Increase Spending on Type 1 Diabetes Cure Research.
- Adocia Reports Topline Results of BioChaperone® Glucagon Phase 1 Study. See also Biochaperone® Human Glucagon: A Stable Solution of Recombinant Human Glucagon.
November 22, 2017
October 18, 2017
- Artificial Pancreas performs well in clinical trial.
- Patients face tough choices when a healthcare provider calls it quits.
- Lenny Kravitz rocked the Carousel Ball to $1.65 million raised for Type 1 diabetes.
- Maharashtra: 24 young adults suffering from Type 1 diabetes scale state’s highest peak.
- No More Finger Prick. New Technology May Help with Diabetes Management.
- Will High-Tech Skin Put an End to Needle Sticks for Diabetes?
October 11, 2017
advertisement
